Authors
Latest:
Preventing Adverse Drug Events: A Call to Action for PharmacistsNational Adverse Drug Event Awareness Day was established to promote awareness, drive policy changes, and encourage health care professionals and patients to prioritize medication safety.
Latest:
Ending the HIV Epidemic: How to Get Back on TrackPrEP reduces the risk of getting HIV from sex by about 99% for certain patient population with consistent adherence.
Latest:
Psilocybin at the Crossroads: Regulatory Barriers and the Pharmacist’s Role in Palliative InnovationAbigail Thomas, PharmD, and Lee A. Kral, PharmD, discuss the evolving role of psilocybin-assisted therapy in palliative care, highlighting current evidence, safety concerns, and how pharmacists can guide patient selection, manage drug interactions, and support education as the therapy moves closer to clinical use.
Latest:
Interactive Case Studies- February 2023Cases discuss patients with medication allergies and drug interactions.
Latest:
The Impact of USP 797, USP 800 on Compounding PharmaciesUSP 800 was a necessary step to maximize safety, but it also recommended many institutions reevaluate their facilities, equipment, processes, and staffing capacity, potentially costing millions of dollars.
Latest:
Management of Diabetes During RamadanIt is imperative for health care professionals, especially pharmacists, to be well-informed regarding the physiological impact of Ramadan on diabetes.
Latest:
Oncology Overview: Omidubicel Stem Cell Therapy ProductOmidubicel is a stem cell-based product that utilizes nicotinamide to inhibit differentiation and to increase the migration, bone marrow homing, and engraftment efficiency of hematopoietic progenitor cells.
Latest:
Commentary: I’m a Mother, PharmD, and Grateful for the Opportunities Still AheadThe pharmacy industry operates through people with different talents filling all types of responsibilities.
Latest:
High Drug Prices: How We Got Here and How We Achieve AffordabilityAffordability in drug pricing can be addressed by bringing the manufacturer and plan sponsor to negotiate costs and determine fair compensation for product and service providers in the supply chain.
Latest:
HLA-DQA1*05 Genotype Does Not Influence Clinical Response to Ustekinumab, VedolizumabNo significant demographic or phenotypic differences were found between HLA-DQA1*05 carriers versus non-carriers, in either treatment group.
Latest:
Pharmacists Play a Crucial Role When Addressing Health LiteracyProviders who are sensitive to health literacy have contributed to positive quality improvement across various institutions.
Latest:
Modernizing Health Care With DigiceuticalsExplore the definition of digiceuticals, current digiceutical products available, and pharmacy implications.
Latest:
Multilingual Pharmacists Create Bridge of Communication, Access for PatientsLanguage barriers between pharmacists and patients impacts medication adherence, patient education, and overall health outcomes, resulting in patient harm.
Latest:
Operational, Managerial, and Clinical Takeaways from National Association of Specialty Pharmacy Annual MeetingPoster presentations and speaking sessions at NASP showed the importance of clinical pharmacists in ambulatory care and opportunities to expand specialty pharmacy services in ambulatory care.
Latest:
Empowering Diabetes Care: The Evolving Role of PharmacistsPharmacists are well-positioned to address diabetes from a multifaceted approach.
Latest:
Management of Diabetes During RamadanIt is imperative for health care professionals, especially pharmacists, to be well-informed regarding the physiological impact of Ramadan on diabetes.
Latest:
The Impact of Xylazine on Overdose ResponsePharmacists and health care providers should be familiar with the management of xylazine overdose and withdrawal.
Latest:
Lessons Learned on InstagramIn 2019, an article in the Journal of the American College of Clinical Pharmacy encouraged pharmacists to engage professionally on social media, despite their having mostly avoided it for such purposes.
Latest:
New BiTE Agents Provide Effective Options for Treatment of Relapsed/Refractory Multiple MyelomaSeven new agents have received FDA approval since October 2022.
Latest:
Biosimilars: Are They Delivering the Cost Savings Promised?Since the first FDA biosimilar approval of filgrastim-sndz (Zarxio) in 2015, a total of 44 biosimilars for 15 originator products have been approved and more than 20 are marketed.
Latest:
Oral Oncolytics Expand Armamentarium in HR+/HER– Early-Stage Breast Cancer in Adjuvant SettingNew agents can offer a more tailored approach to therapy selection.
Latest:
NLA 2025: Bempedoic Acid Supports ASCVD Prevention and LDL-C ReductionBempedoic acid is an effective option for statin-intolerant patients or those needing additional low-density lipoprotein cholesterol (LDL-C) reduction, with clinical trials showing cardiovascular benefits, key drug-drug interaction considerations, and special management factors in patients with comorbidities.
Latest:
The Evolving Role of the Pharmacist in Addressing the Opioid EpidemicPharmacists' expertise is invaluable to prescribers who are unfamiliar with opioid use disorder treatment protocols.
Latest:
The Promise of Psilocybin-Assisted Therapy for Opioid Use DisorderWith Oregon, Colorado, and New Mexico legalizing psilocybin-assisted therapy, opportunities for treatment are expanding.
Latest:
Prevalence of Dosage Modifications and Impact on Response Milestone Among Patients With CML Treated With Imatinib Using RWDThis abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025.
Latest:
Personalized Prevention: Identifying At-Risk Patients With Image-Based ScreeningAnna Sophie Mueller, MD discusses how imaging could advance risk identification in cardiovascular care.
Latest:
The Not So New Role of Pharmacists: No Longer an Overlooked Health Care ProviderPharmacists are critically important in care delivery in their ability to influence patient success, patient-reported outcomes, and quality of life while reducing the burden on physicians and their clinical support teams.
Latest:
Reconciling Medications in Mental Health Assessments Protects PatientsProcess helps prevent errors for individuals with chronic disorders who often have a higher risk of drug-drug interactions.
Latest:
AACR Precision Medicine 2025: AACR Past-President Elaine R. Mardis, PhD, Discusses Highlights of the Meeting for PharmacistsConference Co-Chair and American Association for Cancer Research (AACR) Past President Elaine R. Mardis, PhD, explains that the conference provides pharmacy professionals with insights into the application of large-scale cancer genomics studies to real-world therapeutic responses.
